SCHEMBL7847293

SCHEMBL7847293

O=C1c2ccc(CN3C(=O)c4ccccc4C3=O)cc2CC1Br

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.49
PKM P14618 1/20 0.49
TSHR P16473 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
CASP3 P42574 3/20 0.43
HPGD P15428 2/20 0.43
PABPC1 P11940 1/20 0.43
ALOX15 P16050 1/20 0.43
MAPK1 P28482 1/20 0.43
MAPT P10636 1/20 0.43
HTT P42858 1/20 0.43
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA9 Q16790 1/20 0.43
ADRA1D P25100 2/20 0.41
ADRA1A P35348 2/20 0.41
ADRA1B P35368 2/20 0.41
HDAC1 Q13547 2/20 0.41
HDAC7 Q8WUI4 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7844959 0.74 KMT2A (0.54) KMT2APKMTSHRSMN1; SMN2CASP3
SCHEMBL7848848 0.72 KDM4E (0.40) KMT2APKMTSHRSMN1; SMN2CASP3
SCHEMBL296403 0.72 ACHE (0.59) KMT2ATSHRSMN1; SMN2MAPTMEN1
SCHEMBL29752636 0.72 ACHE (0.59) KMT2ATSHRSMN1; SMN2MAPTMEN1
SCHEMBL2258501 0.70 KMT2A (0.70) KMT2APKMTSHRSMN1; SMN2CASP3
SCHEMBL17029125 0.70 CASP3 (0.66) KMT2APKMTSHRSMN1; SMN2CASP3
SCHEMBL2040789 0.70 CA12 (0.55) KMT2APKMTSHRSMN1; SMN2CASP3
SCHEMBL6206085 0.69 TDP2 (0.47) KMT2ASMN1; SMN2HPGDMAPTHTT
SCHEMBL20267510 0.69 KMT2A (0.50) KMT2APKMTSHRSMN1; SMN2CASP3
SCHEMBL8331387 0.69 KMT2A (0.50) KMT2APKMTSHRSMN1; SMN2CASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820455-B1 5H, 10H-IMIDAZO [1,2-a]INDENO [1,2-e]PYRAZIN-4-ONE DERIVATIVES, PREPARATION THEREOF, AND DRUGS CONTAINING SAID DERIVATIVES AVENTIS PHARMA SA (FR) 2001-10-31 EP disclosed
CN-1063180-C 5H, 10H-imidazo [1, 2 -a] indeno [1, 2 -e] pyrazin-4-one derivatives, preparation thereof, and drugs containing said derivatives RHONE POULENC RORER SA (FR) 2001-03-14 CN disclosed
US-6057454-A USEFUL FOR TREATING OR PREVENTING ALL ISCHAEMIAS (SUCH AS FOCAL OR GLOBAL ISCHAEMIA) RESULTING FROM CEREBROVASCULAR DISORDERS RHONE-POULENC RORER S.A. (FR) 2000-05-02 US disclosed
US-5902803-A 5H,10H-imidazo 1,2-a!indeno 1,2-e!pyrazin-4-one derivatives, preparation thereof, and drugs containing said derivatives RHONE-POULENC RORER S.A. (FR) 1999-05-11 US disclosed
CN-1180357-A 5H, 10H-imidazo [1, 2-a ] indeno [1, 2-e ] pyrazin-4-one derivatives, preparation thereof and medicaments containing same RHONE POULENC RORER SA (FR) 1998-04-29 CN disclosed
EP-0820455-A1 5H, 10H-IMIDAZO [1,2-a]INDENO [1,2-e]PYRAZIN-4-ONE DERIVATIVES, PREPARATION THEREOF, AND DRUGS CONTAINING SAID DERIVATIVES Aventis Pharma S.A. (FR) 1998-01-28 EP disclosed
WO-1996031511-A1 5H,10H-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZIN-4-ONE DERIVATIVES, PREPARATION THEREOF, AND DRUGS CONTAINING SAID DERIVATIVES RHONE-POULENC RORER S.A. (FR) 1996-10-10 WO disclosed